If Axonics Modulation Technologies, Inc.'s attempt to challenge sacral neuromodulation patents held byMedtronic plc made for a medtech David versus Goliath story, then the US Patent and Trademark Office’s rulings in the case were a knockout blow for the Minnesota medical device giant.
The Patent Trial and Appeals Board (PTAB) announced on 22 September that it would uphold the final three patents that...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?